RT Journal Article
SR Electronic
T1 Update on drugs for herpes zoster and genital herpes
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 77
OP 79
DO 10.1136/dtb.1998.361077
VO 36
IS 10
YR 1998
UL http://dtb.bmj.com/content/36/10/77.abstract
AB We reviewed the use of aciclovir (Zovirax - Glaxo Wellcome) 6 years ago.1 Since then, two more oral antiherpetic drugs have been licensed - famciclovir (Famvir - SmithKline Beecham) and valaciclovir (Valtrex - Glaxo Wellcome). Here we discuss their efficacy and safety, and review their place in the management of patients with herpes zoster (shingles) and genital herpes, comparing them with aciclovir.